CTHRC1 and familial pancreatic carcinoma: To investigate the influence of the anti-CTHRC1 antibody in vivo, two human pancreatic-cancer-bearing mouse models were established (subcutaneous BxPC-3, Figure 7A; and orthotopic CFPAC-1, Figure 7E).